HUTCHMED (China) (HCM) Return on Assets Growth (1y) (2017 - 2022)
HUTCHMED (China) (HCM) Return on Assets Growth (1y) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.01 Bn | 87.15 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.41 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.56 Bn | 12.14 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 9.57 Bn | 9.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Jun 30, 2020 | 0.00 |
| Mar 31, 2020 | -1.00 |
| Dec 31, 2017 | 0.00 |
| Jun 30, 2017 | 0.00 |